According to Kan et al. and Nault et al., 45.5% of HCC patients display altered Jak/STAT signaling [33,104], although it must be noted that not all of these mutations are found in gp130-associated molecules. This evidence concerns the gene SOAT1 and hepatocellular carcinoma.